Sigma-1 receptor (S1R), another potential therapeutic target gene in ALS discovered by Couly et al., regulates mitochondrial respiration and controls cellular defense against endoplasmic reticulum and oxidative stress [15]. Here, TMBIM4 is linked to amyotrophic lateral sclerosis.